Stromal cytokines, IL-6 in particular, are known to activate tumor cells [23,28], but it is hitherto unclear whether and how increased TNBC aggressiveness and chemoresistance are specifically induced by CAFs. This evidence concerns the gene IL6 and neoplasm.